Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.61 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.56 |
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | S100A4 | P26447 | 1/20 | 0.46 |
| ▸ | TYMS | P04818 | 2/20 | 0.46 |
| ▸ | METAP1 | P53582 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | CASP7 | P55210 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | TDP2 | O95551 | 1/20 | 0.43 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.43 |
| ▸ | HSD17B1 | P14061 | 1/20 | 0.43 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.42 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | CMA1 | P23946 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29804236 | 1.00 | PBRM1 (0.64) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL24753297 | 0.88 | PARP10 (0.53) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL29483386 | 0.88 | MAOA (0.53) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL3006544 | 0.88 | PARP10 (0.53) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL355820 | 0.88 | MAOA (0.53) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL16230083 | 0.88 | TDP1 (0.63) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| Formic Acid Methyl Ester SCHEMBL28108237 | 0.86 | PBRM1 (0.50) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL358939 | 0.84 | TDP1 (0.81) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL598138 | 0.84 | TDP1 (0.61) | PBRM1TDP1L3MBTL1PARP10PARP1 | |
| SCHEMBL27039 | 0.83 | CASP1 (0.59) | PBRM1TDP1L3MBTL1PARP10S100A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 905 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118878820-A | Photocatalytic stilbene synthesized porous poly schiff base material and dye adsorption application | 安徽中天新材料科技股份有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-115724834-A | Indenoquinolinone or chromene quinolinone derivative and preparation method and application thereof | 广东工业大学 | 2023-03-03 | — | — | CN | claimed |
| CN-113861113-B | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2022-12-06 | — | — | CN | claimed |
| CN-113861113-A | Preparation and application of fused ring pyridine compound and derivative thereof | 中国科学院福建物质结构研究所 | 2021-12-31 | — | — | CN | claimed |
| CN-113321617-A | Red light thermal induction delay fluorescent material, preparation method thereof and organic electroluminescent device | 中国科学院长春应用化学研究所 | 2021-08-31 | — | — | CN | claimed |
| CN-112574078-A | 2-sulfuryl-2, 3-dihydro-1-indanone and derivatives and synthesis method thereof | 湖南工程学院 | 2021-03-30 | — | — | CN | claimed |
| CN-112029743-A | Bio-enzyme catalytic synthesis method of 6-bromoindanone | 江西邦泰绿色生物合成生态产业园发展有限公司 | 2020-12-04 | — | — | CN | claimed |
| EP-3064494-A1 | A PROCESS FOR THE PREPARATION OF A CAMSYLATE SALT ((1S)-(+)-10 CAMPHORSULFONIC ACID) OF (1R,1'R,4R)- 4-METHOXY-5\"-METHYL-6'-[5-(PROP-1-YN-1-YL)PYRIDIN- 3-YL]-3'H-DISPIRO[CYCLOHEXANE-1,2'-INDEN-1'2'-IMIDAZOLE]-4\"-AMINE | AstraZeneca AB (SE) | 2016-09-07 | — | — | EP | claimed |
| EP-4737455-A1 | COMPOUND CONTAINING MULTI-FUSED RING STRUCTURE | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CN) | 2026-05-06 | — | — | EP | disclosed |
| US-20260098028-A1 | Compounds and Their Use for Treatment of Hemoglobinopathies | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-04-09 | — | — | US | disclosed |
| US-20260098037-A1 | COMPOUND CONTAINING MULTI-FUSED RING STRUCTURE | CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN) | 2026-04-09 | — | — | US | disclosed |
| EP-3950676-B1 | PREPARATION METHOD FOR AMIDE COMPOUNDS AND APPLICATION THEREOF IN FIELD OF MEDICINE | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) | 2026-04-08 | — | — | EP | disclosed |
| US-12595267-B2 | Preparation method for amide compound and application thereof in field of medicine | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) | 2026-04-07 | — | — | US | disclosed |
| EP-3950682-B1 | PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD | SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) | 2026-02-11 | — | — | EP | disclosed |
| WO-1994026692-A1 | BICYCLIC AMIDE DERIVATIVES AND THEIR USE AS MUSCLE RELAXANTS | THE WELLCOME FOUNDATION LIMITED (GB) | 1994-11-24 | — | — | WO | disclosed |
| EP-0357742-B1 | NEW PYRETHRINOID ESTERS CARRYING AN INDANYL RING, PREPARATION METHOD AND APPLICATION AS PESTICIDES | ROUSSEL-UCLAF (FR) | 1993-06-09 | — | — | EP | disclosed |
| EP-0240859-B1 | LIPOXYGENASE INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1993-04-28 | — | — | EP | disclosed |
| US-5180741-A | Insecticides | ROUSSEL UCLAF (FR) | 1993-01-19 | — | — | US | disclosed |
| EP-0357742-A1 | NEW PYRETHRINOID ESTERS CARRYING AN INDANYL RING, PREPARATION METHOD AND APPLICATION AS PESTICIDES. | ROUSSEL UCLAF (FR) | 1990-03-14 | — | — | EP | disclosed |
| WO-1989008096-A1 | NEW PYRETHRINOID ESTERS CARRYING AN INDANYL RING, PREPARATION METHOD AND APPLICATION AS PESTICIDES | ROUSSEL-UCLAF (FR) | 1989-09-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12595267-B2 | Preparation method for amide compound and application thereof in field of medicine | EZH2, BMI1, EHMT1 | PBRM1 51/4885TDP1 3871/4885L3MBTL1 1175/4885 |
| US-20260098037-A1 | COMPOUND CONTAINING MULTI-FUSED RING STRUCTURE | SLC5A2, SLC5A11, SLC5A1 | PBRM1 2464/4885TDP1 3935/4885L3MBTL1 4806/4885 |
| US-20260098028-A1 | Compounds and Their Use for Treatment of Hemoglobinopathies | HBZ, HBG2, HBB | PBRM1 3544/4885TDP1 4327/4885L3MBTL1 2154/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.